{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:06:53Z","timestamp":1790705213936,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The clinical and genetic heterogeneity of hereditary ataxias presents a significant diagnostic challenge, particularly in sporadic adult-onset cases. Spinocerebellar ataxia type 27B (SCA27B) is caused by an intronic GAA\u00b7TTC repeat expansion in the fibroblast growth factor 14 (F\n                      <jats:italic>GF14<\/jats:italic>\n                      ) gene and is inherited in an autosomal dominant manner, although with reduced penetrance. This novel ataxia is emerging as a frequent yet underdiagnosed cause of late-onset often sporadic cerebellar ataxia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>In this study, we describe our experience in clinical presentation, neuroimaging characteristics (including MR spectroscopy of the cerebellum), tremor analysis, and therapeutic response to 3,4-diaminopyridine in a cohort of 50 patients with SCA27B.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age at onset was 61.8\u00a0years. Episodic symptoms were reported in 28% of cases, while downbeat nystagmus and oscillopsia were observed in 50% and 28% individuals\n                      <jats:underline>,<\/jats:underline>\n                      respectively. Tremor was also present in 22% of patients. Tremor analysis demonstrated bilateral, intermediate-frequency (~\u20096\u00a0Hz) tremor with both action and resting components, occasionally involving, apart from arms, the lower limbs and head. MRI findings revealed involvement of the superior cerebellar peduncle, and MR spectroscopy of the cerebellum (MRS) demonstrated a progressive decline in NAA\/Cr area ratios in the cerebellar hemisphere over time. Notably, treatment with 3,4-diaminopyridine was associated with subjective symptom improvement in most patients and objective stabilization and\/or improvement on MRS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings expand the clinical, neuroimaging and tremor phenotype of SCA27B and support the use of 3,4-diaminopyridine as a potentially effective therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-025-13422-4","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T05:09:41Z","timestamp":1759986581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical characteristics, cerebellar MR spectroscopy and response to 3,4-diaminopyridine in spinocerebellar ataxia 27B: the Sheffield Ataxia Centre experience"],"prefix":"10.1007","volume":"272","author":[{"given":"Ikechukwu","family":"Chukwuocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pellerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Shanmugarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theocharis","family":"Tsironis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Hoggard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Beauchamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Turton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisdair","family":"McNeill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Brais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2542-8954","authenticated-orcid":false,"given":"Marios","family":"Hadjivassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"no. 5","key":"13422_CR1","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1007\/s12311-024-01703-z","volume":"23","author":"LI Rudaks","year":"2024","unstructured":"Rudaks LI, Yeow D, Ng K, Deveson IW, Kennerson ML, Kumar KR (2024) An update on the adult-onset hereditary cerebellar ataxias: novel genetic causes and new diagnostic approaches. Cerebellum 23(5):2152\u20132168","journal-title":"Cerebellum"},{"issue":"2","key":"13422_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1056\/NEJMoa2207406","volume":"388","author":"D Pellerin","year":"2023","unstructured":"Pellerin D et al (2023) Deep intronic FGF14 GAA repeat expansion in late-onset cerebellar ataxia. N Engl J Med 388(2):128\u2013141","journal-title":"N Engl J Med"},{"issue":"1","key":"13422_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1504","volume":"14","author":"D Pellerin","year":"2024","unstructured":"Pellerin D et al (2024) Spinocerebellar ataxia 27B: a novel, frequent and potentially treatable ataxia. Clin Transl Med 14(1):e1504","journal-title":"Clin Transl Med"},{"issue":"10","key":"13422_CR4","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1093\/brain\/awad157","volume":"146","author":"C Wilke","year":"2023","unstructured":"Wilke C et al (2023) GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response. Brain 146(10):4144\u20134157","journal-title":"Brain"},{"issue":"5","key":"13422_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad239","volume":"5","author":"C Ashton","year":"2023","unstructured":"Ashton C et al (2023) Spinocerebellar ataxia 27B: episodic symptoms and acetazolamide response in 34 patients. Brain Commun 5(5):fcad239","journal-title":"Brain Commun"},{"issue":"105076","key":"13422_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105076","volume":"102","author":"D Pellerin","year":"2024","unstructured":"Pellerin D et al (2024) GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort. EBioMedicine 102(105076):105076","journal-title":"EBioMedicine"},{"issue":"5","key":"13422_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.neurol.2024.03.007","volume":"180","author":"G Cl\u00e9ment","year":"2024","unstructured":"Cl\u00e9ment G, Puisieux S, Pellerin D, Brais B, Bonnet C, Renaud M (2024) Spinocerebellar ataxia 27B (SCA27B), a frequent late-onset cerebellar ataxia. Rev Neurol (Paris) 180(5):410\u2013416","journal-title":"Rev Neurol (Paris)"},{"key":"13422_CR8","unstructured":"Pellerin D et al (1993) GAA-FGF14-related ataxia. In: GeneReviews(\u00ae), University of Washington, Seattle"},{"issue":"1","key":"13422_CR9","doi-asserted-by":"publisher","first-page":"9737","DOI":"10.1038\/s41598-023-36654-8","volume":"13","author":"C Bonnet","year":"2023","unstructured":"Bonnet C et al (2023) Optimized testing strategy for the diagnosis of GAA-FGF14 ataxia\/spinocerebellar ataxia 27B. Sci Rep 13(1):9737","journal-title":"Sci Rep"},{"key":"13422_CR10","unstructured":"The genetic landscape and phenotypic spectrum of GAA-FGF14 ataxia in China: a large cohort study Author links open overlay panel Riwei Ouyang"},{"issue":"5","key":"13422_CR11","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s12311-020-01152-4","volume":"19","author":"M Hadjivassiliou","year":"2020","unstructured":"Hadjivassiliou M et al (2020) Treatment of primary autoimmune cerebellar ataxia with mycophenolate. Cerebellum 19(5):680\u2013684","journal-title":"Cerebellum"},{"issue":"no. 4","key":"13422_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/ene.12350","volume":"21","author":"M Rossi","year":"2014","unstructured":"Rossi M et al (2014) Autosomal dominant cerebellar ataxias: a systematic review of clinical features. Eur J Neurol 21(4):607\u2013615","journal-title":"Eur J Neurol"},{"issue":"4","key":"13422_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/ctn8040029","volume":"8","author":"E Nuzhnyi","year":"2024","unstructured":"Nuzhnyi E et al (2024) Clinical and video-oculographic characteristics of spinocerebellar ataxia type 27B (GAA-FGF14 ataxia): a single-center retrospective study. Clin Transl Neurosci 8(4):29","journal-title":"Clin Transl Neurosci"},{"issue":"7","key":"13422_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70247","volume":"32","author":"J Theuriet","year":"2025","unstructured":"Theuriet J et al (2025) Neuropathy in GAA-FGF14 late-onset cerebellar ataxia (SCA27B): Prevalence and characteristics. Eur J Neurol 32(7):e70247","journal-title":"Eur J Neurol"},{"issue":"3","key":"13422_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.14802\/jmd.16028","volume":"9","author":"K-D Choi","year":"2016","unstructured":"Choi K-D, Choi J-H (2016) Episodic ataxias: clinical and genetic features. J Mov Disord 9(3):129\u2013135","journal-title":"J Mov Disord"},{"issue":"10","key":"13422_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047479","volume":"7","author":"P-S Wang","year":"2012","unstructured":"Wang P-S, Chen H-C, Wu H-M, Lirng J-F, Wu Y-T, Soong B-W (2012) Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6. PLoS ONE 7(10):e47479","journal-title":"PLoS ONE"},{"key":"13422_CR17","doi-asserted-by":"crossref","unstructured":"Chen S et al (2024) Neuroradiological findings in GAA-FGF14 ataxia (SCA27B): more than cerebellar atrophy. medRxiv, p. 2024.02.16.24302945","DOI":"10.1101\/2024.02.16.24302945"},{"issue":"3","key":"13422_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.14802\/jmd.19002","volume":"12","author":"H Kataoka","year":"2019","unstructured":"Kataoka H et al (2019) Increased signal in the superior cerebellar peduncle of patients with progressive supranuclear palsy. J Mov Disord 12(3):166\u2013171","journal-title":"J Mov Disord"},{"issue":"no. 105131","key":"13422_CR19","doi-asserted-by":"publisher","first-page":"105131","DOI":"10.1016\/j.ebiom.2024.105131","volume":"103","author":"E Indelicato","year":"2024","unstructured":"Indelicato E, Boesch S (2024) GAA\/FGF14 ataxia: an ode to the phenotype-first approach. EBioMedicine 103(105131):105131","journal-title":"EBioMedicine"},{"issue":"1","key":"13422_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.nbd.2008.09.019","volume":"33","author":"VG Shakkottai","year":"2009","unstructured":"Shakkottai VG et al (2009) FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons. Neurobiol Dis 33(1):81\u201388","journal-title":"Neurobiol Dis"},{"issue":"17","key":"13422_CR21","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1523\/JNEUROSCI.2663-14.2015","volume":"35","author":"MK Bosch","year":"2015","unstructured":"Bosch MK, Carrasquillo Y, Ransdell JL, Kanakamedala A, Ornitz DM, Nerbonne JM (2015) Intracellular FGF14 (iFGF14) is required for spontaneous and evoked firing in cerebellar Purkinje neurons and for motor coordination and balance. J Neurosci 35(17):6752\u20136769","journal-title":"J Neurosci"},{"issue":"4","key":"13422_CR22","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/WNO.0b013e3182258086","volume":"31","author":"R Kalla","year":"2011","unstructured":"Kalla R et al (2011) Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus. J Neuroophthalmol 31(4):320\u2013325","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"13422_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/0006-8993(84)90875-8","volume":"304","author":"M Lemeignan","year":"1984","unstructured":"Lemeignan M, Millart H, Lamiable D, Molgo J, Lechat P (1984) Evaluation of 4-aminopyridine and 3,4-diaminopyridine penetrability into cerebrospinal fluid in anesthetized rats. Brain Res 304(1):166\u2013169","journal-title":"Brain Res"},{"issue":"8","key":"13422_CR24","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/mds.29559","volume":"38","author":"H Hengel","year":"2023","unstructured":"Hengel H et al (2023) As frequent as polyglutamine spinocerebellar ataxias: SCA27B in a large German autosomal dominant ataxia cohort. Mov Disord 38(8):1557\u20131558","journal-title":"Mov Disord"},{"issue":"8","key":"13422_CR25","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/mds.29552","volume":"38","author":"D Pellerin","year":"2023","unstructured":"Pellerin D et al (2023) Non-GAA repeat expansions in FGF14 are likely not pathogenic-reply to: \u2018shaking up ataxia: FGF14 and RFC1 repeat expansions in affected and unaffected members of a Chilean family.\u2019 Mov Disord 38(8):1575\u20131577","journal-title":"Mov Disord"},{"issue":"1","key":"13422_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11910-024-01400-8","volume":"25","author":"D Pellerin","year":"2025","unstructured":"Pellerin D et al (2025) Recent advances in the genetics of ataxias: an update on novel autosomal dominant repeat expansions. Curr Neurol Neurosci Rep 25(1):16","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"104994","key":"13422_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.104994","volume":"100","author":"BP van de Warrenburg","year":"2024","unstructured":"van de Warrenburg BP, Kamsteeg E-J (2024) The FGF14 gene is a milestone in ataxia genetics. EBioMedicine 100(104994):104994","journal-title":"EBioMedicine"},{"issue":"104931","key":"13422_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104931","volume":"99","author":"J-L M\u00e9reaux","year":"2024","unstructured":"M\u00e9reaux J-L et al (2024) Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions. EBioMedicine 99(104931):104931","journal-title":"EBioMedicine"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13422-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13422-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13422-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T01:06:12Z","timestamp":1761699972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13422-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["13422"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13422-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"681"}}